Literature DB >> 30829007

Recurrent Kawasaki disease at a tertiary care center in Chandigarh, North West India: 24 years of clinical experience.

Sandesh Guleria1, Rakesh Kumar Pilania1, Ankur Kumar Jindal1, Dharmagat Bhattarai1, Deepti Suri1, Surjit Singh1.   

Abstract

BACKGROUND: Kawasaki disease (KD) is emerging as the most common medium vessel vasculitis in children. Recurrence of KD (0.8%-3.0%) is unusual and not commonly reported.
OBJECTIVE: To study the clinico-laboratory profile of children with recurrent KD.
METHODS: Case records of 714 children with KD, registered from January 1994 to April 2018 in the Pediatric Rheumatology Clinic at the Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research Chandigarh, were reviewed and data were analyzed for children having had recurrent KD.
RESULTS: Seven (0.98%) children (five boys; two girls) had recurrent KD in our cohort of 714 patients. Mean age at diagnosis was 4.3 years (range, 2-9 years). Six (85.7%) had recurrence of KD within 1.5 years. Incomplete KD was more common during recurrence (71.4%) as compared to the first episode (33.3%). Five children with recurrent KD developed desquamation during the first week of illness. Laboratory investigations did not show any significant difference during the two episodes of KD. Six of the seven children in the first episode received treatment with intravenous immunoglobulin (IVIG). Five of the seven children received IVIG during recurrence. One child had transient left main coronary artery ectasia during the first episode of KD as well as during recurrence and it normalized after treatment on both occasions.
CONCLUSION: Recurrences in KD are unusual. Over a period of 24 years the recurrence rate in our cohort of children with KD was 0.98%. Further, children with recurrences tended to have milder and incomplete form of the disease.
© 2019 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Kawasaki disease; coronary artery aneurysm; intravenous immunoglobulin; periungual desquamation; vasculitis

Mesh:

Substances:

Year:  2019        PMID: 30829007     DOI: 10.1111/1756-185X.13519

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

1.  Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome.

Authors:  Grazia Bossi; Alessia Claudia Codazzi; Federica Vinci; Edoardo Clerici; Corrado Regalbuto; Carmela Crapanzano; Daniele Veraldi; Alice Moiraghi; Gian Luigi Marseglia
Journal:  Children (Basel)       Date:  2022-05-05

2.  SARS-CoV-2 infection triggering recurrence of Kawasaki disease in a 10-year-old child.

Authors:  Ashok Renganathan; Ankit Garg; Sona Chowdhary; Dinesh Raj
Journal:  BMJ Case Rep       Date:  2021-03-24

Review 3.  Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature.

Authors:  Alice Annalisa Medaglia; Lucia Siracusa; Claudia Gioè; Salvatore Giordano; Antonio Cascio; Claudia Colomba
Journal:  Ital J Pediatr       Date:  2021-04-19       Impact factor: 2.638

4.  Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach.

Authors:  Ken-Pen Weng; Ching-Feng Cheng; Kuang-Jen Chien; Luo-Ping Ger; Shih-Hui Huang; Kuo-Wang Tsai
Journal:  Curr Issues Mol Biol       Date:  2021-06-25       Impact factor: 2.976

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.